We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
59.00 | 3.18% | 1,913.00 | 1,916.00 | 1,918.00 | 1,920.00 | 1,861.00 | 1,861.00 | 522,491 | 16:35:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.88B | 192M | 0.8685 | 22.08 | 4.24B |
Date | Subject | Author | Discuss |
---|---|---|---|
21/7/2022 20:37 | 4th August, figures, I expect nothing spectacular, just steady has she's goes, dividend increase, just like it has been for the last 15 years. | montyhedge | |
21/7/2022 15:47 | Slowly getting back over 2000p, figures will give Hikma a push. | montyhedge | |
18/7/2022 09:32 | Two steps forward, one back, but on our way back to 2600p, figures due shortly should give more momentum to upside. | montyhedge | |
16/7/2022 07:06 | Another for the filter button! | blue59 | |
15/7/2022 18:37 | Nah that your mum mate - gave me a blow for free | scepticalinvestor | |
14/7/2022 19:22 | Skeppy Investor - Specialist in LOSING MONEY | buy2sell1 | |
14/7/2022 15:24 | Hikma I would have thought should be upgraded on weak sterling, perhaps after the figures in a couple of weeks time. | montyhedge | |
14/7/2022 15:12 | Sterling coming down nicely, like we said Ftse 100 dollar earners increased profits and dividends. | montyhedge | |
14/7/2022 07:11 | Robertball - ditto! | blue59 | |
13/7/2022 18:10 | Bit of a bargepole now but it will come right after TU imo | scepticalinvestor | |
13/7/2022 18:10 | No CEO. Governance concerns. | robertball | |
13/7/2022 16:22 | Hi everyone, I am increasingly lost with this stock..pharma with low P/E, profitable and growing.. am I missing something obvious? | lamia0231 | |
12/7/2022 14:04 | From 1650p to 2600p in three months 2020.With the pound at a two low against the dollar, perhaps another quick run up boys. Weak pound great for profits and our dividends.Astra, GSK, Glencore will al benefit from weak pound. | montyhedge | |
12/7/2022 12:34 | What we want pound to go to 1.10 to dollar, I worked out forecast p.e 7.8 if my sums correct at that price.Which for a pharma stock would be cheap, still 4th August interims will reveal all. | montyhedge | |
12/7/2022 11:54 | Yes, current buybacks doing nothing really | scepticalinvestor | |
08/7/2022 10:58 | Interims due 4th August, I expect further dividend increase, about time a special or more buybacks comes along. | montyhedge | |
07/7/2022 15:28 | Other pharma's reaching all time highs, must admit don't know why investors leaving Hikma alone, forecast p.e.10, grown dividends last fifteen years also buybacks. Down 35% on record profits, it's a head scratcher. | montyhedge | |
07/7/2022 12:41 | Will Hikma like 2020 go from 1600p to 2600p in around 3 months, looking back at the chart, would be nice. | montyhedge | |
06/7/2022 15:48 | Pound now 1.1894, 1.12 if Boris goes.Great for profits and dividends when converted. | montyhedge | |
06/7/2022 09:07 | On our way to Barclays target of 2500p coming months, weak pound bigger profits and dividends.FTSE 100 dollar earners, GSK, Glencore, Astra all going to benefit with pound at this level. | montyhedge | |
05/7/2022 20:48 | Pound now 1.955 great news for Ftse dollar earners. | montyhedge | |
04/7/2022 09:31 | Is this the run we had in April 2020 from 1650p to 2600p in a few months.I know someone said because of Covid. | montyhedge |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions